Smith+Nephew’s TESSA Spatial Surgery System Wins FDA De Novo Classification in Sports Medicine
Smith+Nephew (SNN) received FDA De Novo classification for its TESSA Spatial Surgery System, a significant regulatory milestone.
Read the full story on market.news
🇨🇦 Canada Stocks Regulatory healthcare biotech regulatory canada uk
What is your take? Drop your thoughts below. 